With the aging of the population, changes in diet and medical examination popular, the incidence and mortality of prostate cancer in China are increasing year by year. Over the past year, a large number of clinical and basic researchers focus on various perspectives of prostate cancer, which may provide new direction for the clinical diagnosis and treatment of prostate cancer. In this paper, the near year important progress in the forefront of prostate cancer has been reviewed and summed up in two major aspects: diagnosis and treatment.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Zhonghua wai ke za zhi [Chinese journal of surgery]. 2017 Jan 01 [Epub]
H Z Li, Y S Zhang
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.